Prevention of Adverse Drug Reactions in Hospitalised Older Patients Using a Software-Supported Structured Pharmacist Intervention: A Cluster Randomised Controlled Trial

Drugs and Aging

Volumn 33, Issue 1, 2016, Pages 63-73

  O’Sullivan, David ^a   O’Mahony, Denis ^b,c   O’Connor, Marie N ^b   Gallagher, Paul ^b,c   Gallagher, James ^a   Cullinan, Shane ^a   O’Sullivan, Richard ^a   Eustace, Joseph ^a   Byrne, Stephen ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Department of Medicine National University of Ireland Cork   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; COLCHICINE; CORTICOSTEROID; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPNOTIC AGENT; METFORMIN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VASODILATOR AGENT; VERAPAMIL;

ACUTE KIDNEY FAILURE; AGED; AGING; ARTICLE; BLEEDING; BRADYCARDIA; CLINICAL DECISION MAKING; COGNITIVE DEFECT; COMPUTER PROGRAM; CONSTIPATION; DELIRIUM; DIARRHEA; DIZZINESS; DRUG SURVEILLANCE PROGRAM; DYSPEPSIA; ELECTROLYTE DISTURBANCE; EPIGASTRIC BURNING; EPIGASTRIC PAIN; FATIGUE; FEMALE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LENGTH OF STAY; MALE; MORTALITY; MOTOR DYSFUNCTION; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SIDE EFFECT; CONTROLLED STUDY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOSPITALIZATION; INAPPROPRIATE PRESCRIBING; ORGANIZATION AND MANAGEMENT; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; LENGTH OF STAY; MALE; PATIENT DISCHARGE; PHARMACISTS; SOFTWARE;

EID: 84953835705     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-015-0329-y     Document Type: Article

References (32)

1. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.
2. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.
3. Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012;29(6):453–62.
4. O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437–52.
5. Cherubini A, Ruggiero C, Gasperini B, et al. The prevention of adverse drug reactions in older subjects. Curr Drug Metab. 2011;12(7):652–7.
6. Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57(2):121–6.
7. Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31–32):543–51.
8. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22(9):767–77.
9. O’Connor MN, Gallagher P, Byrne S, et al. Adverse drug reactions in older patients during hospitalisation: are they predictable? Age Ageing. 2012;41(6):771–6.
10. Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439.
11. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–9.
12. Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.
13. Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013–28.
14. Spinewine A, Dhillon S, Mallet L, et al. Implementation of ward-based clinical pharmacy services in Belgium—description of the impact on a geriatric unit. Ann Pharmacother. 2006;40(4):720–8.
15. Spinewine A, Swine C, Dhillon S, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55(5):658–65.
16. Murray MD, Ritchey ME, Wu J, et al. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med. 2009;169(8):757–63.
17. Mueller SK, Sponsler KC, Kripalani S, et al. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med. 2012;172(14):1057–69.
18. Schnipper JL, Hamann C, Ndumele CD, et al. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med. 2009;169(8):771–80.
19. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1(4):233–8.
20. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–5.
21. Salvi F, Miller MD, Grilli A, et al. A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc. 2008;56(10):1926–31.
22. WHO. Guidelines for ATC classification and DDD assignment. 2011. http://www.whocc.no/filearchive/publications/2011guidelines.pdf. Accessed Sept 2015.
23. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. 58th ed. London: BMJ Publishing Group; 2011.
24. World Health Organisation (WHO). International drug monitoring—the role of the national centers. Geneva: World Health Organisation (WHO); 1972.
25. Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171(11):1013–9.
26. World Health Organisation (WHO). Causality assessment of suspected adverse reactions. http://who-umc.org/Graphics/24734.pdf. Accessed Sept 2015.
27. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.
28. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229–32.
29. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100(4):428–37.
30. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116(6):394–401.
31. O’Connor M, O’Sullivan D, Gallagher P, et al. Prevention of adverse drug events in hospitalized older patients: a randomised controlled trial using STOPP/START criteria. Eur Geriatr Med. 2012;3:S132.
32. University College Cork. Adverse drug event prevention using structured pharmacist review [ClinicalTrials.gov identifier NCT01467128]. US National Institutes of Health, ClinicalTrials.gov. http://clinicaltrials.gov/show/NCT01467128. Accessed 2 Nov 2015.